Marian Shepard

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
  • Beverly Bethelmie-Bryan, Katharine Lord, +9 authors Hanna Jean Khoury
  • 2013
A multidisciplinary approach offers efficiency and quality care by delegating tasks according to individuals' expertise. However, increasingly stringent regulatory requirements, albeit essential for successful conduct of clinical trials, have magnified the workload of research teams. We describe tools that have efficiently addressed regulatory requirements(More)
Dasatinib (DAS) is a well tolerated oral dual SRC inhibitor with remarkable activity against all phases of imatinib-resistant chronic myeloid leukemia (CML). This paper focuses on the activity of DAS in intractable CML, and reviews outcomes of patients enrolled on DAS clinical trials. Safety and tolerability as well as practical tips for management of(More)
  • 1